Intrinsiqq
Scilex Holding Company logoScilex Holding CompanySCLX
$2.83+0.35%
Scilex Holding Company logo

Scilex Holding Company

SCLX

$2.83

+$0.01 (+0.35%)

⊜ Compare
ProfitabilityUnprofitableGrowthDecliningCash FlowCash burnValuationN/A
What stands out

The business is unprofitable at the operating level (-1143.71% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.

What's changing

Revenue declined 46.5% YoY. Margins deteriorated 996.3pp alongside, both lines moving the wrong way.

What deserves caution

Free cash flow declined 81% versus the prior year, cash generation momentum has weakened. ROIC dropped from -49.76% to -312.20%, capital efficiency is deteriorating.

Price History

-78.7%

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$24M
EPS-$49.73
P/E-0.06
P/FCF-1.41
EV/EBITDA-0.41
FCF Yield—
Div. Yield35.99%
Net Debt/FCF-7.2x
52-Week Range
$2.80$8.49

Profitability & Returns

Revenue (TTM)

$31M

▼ -46.5% YoY

Net Income (TTM)

-$465M

▼ -413.8% YoY

Op. Margin

-1168.68%

▼ -996.3pp YoY

ROIC

-254.14%

▼ -262.4pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$17M

▼ -81.0% YoY

Op. Cash Flow (TTM)

-$17M

▼ -80.3% YoY

Net Debt

$124M

Cash & Equiv.

$566K

5Y CAGR: +5.1%

Continue Research

SourceComputed from the 10-Q filed 10 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.

Price from market data, last close as of 16 Oct 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.

Is Scilex Holding (SCLX) overvalued?

Scilex Holding (SCLX)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.

On quality, Scilex Holding scores 0/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 36.0%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.

Frequently asked

Is Scilex Holding a high-quality business?+

Scilex Holding scores 0 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -1,168.7% operating margin and a -254.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.

Does Scilex Holding (SCLX) pay a dividend, and how much?+

Yes, Scilex Holding pays a regular dividend yielding roughly 36.0%. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For SCLX's full payout history, growth streak and dividend-safety score, see the dividends tab.

Is Scilex Holding a good stock to buy right now?+

That depends on valuation and quality together, not either alone. you should weigh SCLX's valuation and scores 0/100 on quality (lower-quality). It also yields about 36.0%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.

Related stocks: Biological Products, (No Diagnostic Substances)

Spot a number that looks wrong?

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.